title: [Etravirine in clinical practice: Experience in 151 non-naïve patients].
abstract: BACKGROUND
  There are limited data on etravirine (ETV) use in routine clinical practice.
  
  
  METHODS
  The reasons, efficacy and tolerability of its use are retrospectively reviewed.
  
  
  RESULTS
  Overall, 151patients started a regimen containing ETV. The main reasons for prescription were toxicity and virological failure. After a median follow-up of 16months 76.2% of the patients had an undetectable viral load. Patients with detectable HIV-RNA at baseline had a greater risk of failure (31.7% vs 18%; P=.05).
  
  
  CONCLUSIONS
  ETV is safe, effective and durable.
authors.affiliation: Servicio de Enfermedades Infecciosas, Hospital Carlos III, Madrid, España. Electronic address: evalencia.hciii@salud.madrid.org.
authors.forename: M Eulalia
authors.initials: ME
authors.lastname: Valencia Ortega
authors.forename: Victoria
authors.initials: V
authors.lastname: Moreno Celda
authors.forename: Germán
authors.initials: G
authors.lastname: Ramírez-Olivencia
authors.forename: Luz
authors.initials: L
authors.lastname: Martín Carbonero
mesh_terms: D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D011724:Pyridazines / Q000627:therapeutic use*; D011743:Pyrimidines; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; C451734:etravirine
keywords: Dual therapy; Etravirina; Etravirine; Non-naïve patients; Pacientes pretratados; Terapia dual